BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33842303)

  • 1. Machine Learning-Based Ultrasomics Improves the Diagnostic Performance in Differentiating Focal Nodular Hyperplasia and Atypical Hepatocellular Carcinoma.
    Li W; Lv XZ; Zheng X; Ruan SM; Hu HT; Chen LD; Huang Y; Li X; Zhang CQ; Xie XY; Kuang M; Lu MD; Zhuang BW; Wang W
    Front Oncol; 2021; 11():544979. PubMed ID: 33842303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative prediction of pathological grading of hepatocellular carcinoma using machine learning-based ultrasomics: A multicenter study.
    Ren S; Qi Q; Liu S; Duan S; Mao B; Chang Z; Zhang Y; Wang S; Zhang L
    Eur J Radiol; 2021 Oct; 143():109891. PubMed ID: 34481117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Pathological Grading of Hepatocellular Carcinoma Using Ultrasomics of Contrast-Enhanced Ultrasound.
    Wang W; Wu SS; Zhang JC; Xian MF; Huang H; Li W; Zhou ZM; Zhang CQ; Wu TF; Li X; Xu M; Xie XY; Kuang M; Lu MD; Hu HT
    Acad Radiol; 2021 Aug; 28(8):1094-1101. PubMed ID: 32622746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Prediction of Ki-67 Expression in Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics: A Multicenter Study.
    Zhang L; Duan S; Qi Q; Li Q; Ren S; Liu S; Mao B; Zhang Y; Wang S; Yang L; Liu R; Liu L; Li Y; Li N; Zhang L
    J Ultrasound Med; 2023 May; 42(5):1113-1122. PubMed ID: 36412932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study.
    Ren S; Li Q; Liu S; Qi Q; Duan S; Mao B; Li X; Wu Y; Zhang L
    Front Oncol; 2021; 11():749137. PubMed ID: 34804935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.
    Huang H; Ruan SM; Xian MF; Li MD; Cheng MQ; Li W; Huang Y; Xie XY; Lu MD; Kuang M; Wang W; Hu HT; Chen LD
    Br J Radiol; 2022 Feb; 95(1130):20210748. PubMed ID: 34797687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric ultrasomics of significant liver fibrosis: A machine learning-based analysis.
    Li W; Huang Y; Zhuang BW; Liu GJ; Hu HT; Li X; Liang JY; Wang Z; Huang XW; Zhang CQ; Ruan SM; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
    Eur Radiol; 2019 Mar; 29(3):1496-1506. PubMed ID: 30178143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasomics prediction for cytokeratin 19 expression in hepatocellular carcinoma: A multicenter study.
    Zhang L; Qi Q; Li Q; Ren S; Liu S; Mao B; Li X; Wu Y; Yang L; Liu L; Li Y; Duan S; Zhang L
    Front Oncol; 2022; 12():994456. PubMed ID: 36119507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging.
    Li W; Wang W; Liu GJ; Chen LD; Wang Z; Huang Y; Liu JY; Xie XY; Lu MD
    Radiology; 2015 Jun; 275(3):870-9. PubMed ID: 25584708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear wave elastography-based ultrasomics: differentiating malignant from benign focal liver lesions.
    Wang W; Zhang JC; Tian WS; Chen LD; Zheng Q; Hu HT; Wu SS; Guo Y; Xie XY; Lu MD; Kuang M; Liu LZ; Ruan SM
    Abdom Radiol (NY); 2021 Jan; 46(1):237-248. PubMed ID: 32564210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.
    Pei XQ; Liu LZ; Xiong YH; Zou RH; Chen MS; Li AH; Cai MY
    Br J Radiol; 2013 Mar; 86(1023):20120536. PubMed ID: 23392189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
    Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
    Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
    Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
    Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
    Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of a Ultrasomics Signature for Predicting Malignancy in Thyroid Nodules with Hashimoto's Thyroiditis.
    Sun M; Qu H; Xia H; Chen Y; Gao X; Wang Z; Gao R; Qi T
    Acad Radiol; 2024 May; ():. PubMed ID: 38796400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumour cell counts and ultrasomics signature-based nomogram for preoperative prediction of early recurrence of hepatocellular carcinoma after radical treatment.
    Li W; Zhuang BW; Qiao B; Zhang N; Hu HT; Li C; Xie XH; Kuang M; Lu MD; Xie XY; Wang W
    Br J Radiol; 2022 Oct; 95(1139):20211137. PubMed ID: 36165329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver.
    Ding Z; Lin K; Fu J; Huang Q; Fang G; Tang Y; You W; Lin Z; Lin Z; Pan X; Zeng Y
    World J Surg Oncol; 2021 Jun; 19(1):181. PubMed ID: 34154624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging.
    Stollmayer R; Budai BK; Tóth A; Kalina I; Hartmann E; Szoldán P; Bérczi V; Maurovich-Horvat P; Kaposi PN
    World J Gastroenterol; 2021 Sep; 27(35):5978-5988. PubMed ID: 34629814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.